Georgia legislation · 2025-2026 Regular Session
Georgia HB334: Sickle Cell Disease Protection Act; enact
Status: Signed into law, May 5, 2026
A BILL To be entitled an Act to amend Article 7 of Chapter 4 of Title 49 of the Official Code of Georgia Annotated, relating to medical assistance generally, so as to require the Department of Community Health to conduct an annual review of medications and treatment for sickle cell disease for Medicaid recipients; to provide for public input; to provide for an annual report; to provide for related matters; to provide for a short title; to repeal conflicting laws; and for other purposes.
What the bill says
To amend Article 7 of Chapter 4 of Title 49 of the Official Code of Georgia Annotated, relating to medical assistance generally, so as to require the Department of Community Health to conduct an annual review of medications and treatment for sickle cell disease for Medicaid recipients; to provide for public input; to provide for an annual report; to provide for related matters; to provide for a short title; to repeal conflicting laws; and for other purposes.
From the introduced text:
A BILL TO BE ENTITLED To amend Article 7 of Chapter 4 of Title 49 of the Official Code of Georgia Annotated, relating to medical assistance generally, so as to require the Department of Community Health to conduct an annual review of medications and treatment for sickle cell disease for Medicaid recipients; to provide for public input; to provide for an annual report; to provide for related matters; to provide for a short title; to repeal conflicting laws; and for other purposes. BE IT ENACTED BY THE GENERAL ASSEMBLY OF GEORGIA: SECTION 1. This Act shall be known and may be cited as the "Sickle Cell Disease Protection Act." SECTION 2. Article 7 of Chapter 4 of Title 49 of the Official Code of Georgia Annotated, relating to medical assistance generally, is amended by adding a new Code section to read as follows: "49-4-159.5. (a) The department shall conduct an annual review of all medications, forms of treatment, and services that are eligible for coverage under the Medicaid program for Medicaid H. B. LC 57 0194 recipients with a diagnosis of sickle cell disease. The purpose of the annual review shall be to determine if the available covered medications, treatments, and services are adequate to meet the needs of Medicaid recipients with a diagnosis of sickle cell disease, and whether …
Sponsors
- Ed Harbison (D, 15) · primary sponsor
- Omari Crawford (D, 89) · primary sponsor
- Mary Oliver (D, 84)
- Michelle Au (D)
- Inga Willis (D)
- Anne Westbrook (D, 163)
- Edna Jackson (D, 165)
Latest actions
- : Effective Date
- : Act 401
- : House Date Signed by Governor
- : House Sent to Governor
- : House Agreed Senate Amend or Sub
- : Senate Passed/Adopted By Substitute
- : Senate Third Read
- : Senate Taken from Table
- : Senate Tabled
- : Senate Read Second Time
Votes
- Senate Vote #933 (April 2, 2026): 49 yea, 0 nay, passed
- House Vote #867 (April 2, 2026): 149 yea, 18 nay, passed
- House Vote #669 (March 6, 2026): 159 yea, 7 nay, passed
Common questions
- What is HB334?
- HB334 is a bill in the Georgia Legislature (2025-2026 Regular Session): Sickle Cell Disease Protection Act; enact.
- What does HB334 do?
- In its own words: To amend Article 7 of Chapter 4 of Title 49 of the Official Code of Georgia Annotated, relating to medical assistance generally, so as to require the Department of Community Health to conduct an annual review of medications and treatment for sickle cell disease for Medicaid recipients; to provide for public input; to provide for an annual report; to provide for related matters; to provide for a short title; to repeal conflicting laws; and for other purposes.
- What is the status of HB334?
- Signed into law as of May 5, 2026. Latest action: Effective Date (July 1, 2026).
- Who sponsored HB334?
- Ed Harbison (D, 15), with 6 co-sponsors.
- Where is the official record for HB334?
- On the Georgia Legislature website: https://www.legis.ga.gov/legislation/70064
Source: official Georgia record. Tracked by Delilah, AI for legislation across all 50 states and Congress.